Inactive Instrument

Qiagen Share Price Nasdaq

Equities

NL0012169213

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 2.01B 168B Sales 2025 * 2.14B 178B Capitalization 9.67B 807B
Net income 2024 * 404M 33.72B Net income 2025 * 450M 37.56B EV / Sales 2024 * 4.98 x
Net Debt 2024 * 325M 27.13B Net cash position 2025 * 206M 17.23B EV / Sales 2025 * 4.43 x
P/E ratio 2024 *
23.9 x
P/E ratio 2025 *
21.5 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.67%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 01/15/01
Founder 69 29/96/29
Director of Finance/CFO 56 01/99/01
Members of the board TitleAgeSince
Director/Board Member 74 01/11/01
Founder 69 29/96/29
Chairman 66 26/13/26
More insiders
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW